Amoebic liver abscess medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 11: | Line 11: | ||
Pharmocotherapy for ''[[Entamoeba|E histolytica]]'' include | Pharmocotherapy for ''[[Entamoeba|E histolytica]]'' include | ||
{| class="wikitable" | {| class="wikitable" | ||
! | !Site Of Infection | ||
! | !Treatment | ||
|- | |- | ||
! | !Intraluminal infection | ||
| | |Iodoquinol 650mg tid X 20 days <br> Diloxanide furoate 500mg tid X 20 days<br>Paramomycin 30mg/kg/day X 10 days (in 3 divided doses) | ||
|- | |- | ||
! | !Amoebic liver abscess | ||
| | |Metronidazole 800mg tid PO X 10days (500mg qid IV) | ||
|- | |- | ||
! | !Invasive colitis | ||
| | |Metronidazole 800mg tid X 5 days<br> Tinidazole 1 gm bd X 3 days | ||
|} | |} | ||
Revision as of 20:38, 13 February 2017
|
Amoebic liver abscess Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Amoebic liver abscess medical therapy On the Web |
|
American Roentgen Ray Society Images of Amoebic liver abscess medical therapy |
|
Risk calculators and risk factors for Amoebic liver abscess medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]
Overview
Medical Therapy
Pharmocotherapy for E histolytica include
| Site Of Infection | Treatment |
|---|---|
| Intraluminal infection | Iodoquinol 650mg tid X 20 days Diloxanide furoate 500mg tid X 20 days Paramomycin 30mg/kg/day X 10 days (in 3 divided doses) |
| Amoebic liver abscess | Metronidazole 800mg tid PO X 10days (500mg qid IV) |
| Invasive colitis | Metronidazole 800mg tid X 5 days Tinidazole 1 gm bd X 3 days |
Antibiotic treatment Invasive therapeutic procedures 1: ultrasound guided needle aspiration, percutaneous catheter drainage and open surgical abscess drainage